STEPHANIE DEROUIN: Open Payments
NPI 1588102081 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 28 payments from 12 companies in 2025. Trend: 2023 $543 · 2024 $572 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $222 |
| Ferring Pharmaceuticals Inc. | 1 | $109 |
| PFIZER INC. | 4 | $86 |
| Endo USA, Inc. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
| Caris MPI, Inc. | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: GEMTESA, ADSTILADRIN, XTANDI, Nubeqa, BOTOX, PLUVICTO, XIAFLEX, PROVENGE.
Industry payments across FL — which companies pay providers there.
